Anuh Pharma reclassifies nine shareholders to public category
Anuh Pharma Limited applied to exchanges on May 25, 2026 to reclassify nine shareholders from the promoter group to the public category under Regulation 31A of SEBI LODR Regulations, 2015. The shareholders, holding 0.95% of the paid-up capital, are immediate relatives of promoters no longer involved in management.

*this image is generated using AI for illustrative purposes only.
Anuh Pharma Limited has applied to the stock exchanges on May 25, 2026 to reclassify nine shareholders from the promoter group to the public category. The application follows a Board meeting held on May 20, 2026, which approved the requests received from these shareholders on May 19, 2026. The reclassification is sought under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The shareholders collectively hold 9,49,988 equity shares, representing 0.95% of the company's total paid-up share capital. The applicants include Kinjal Siddharth Jhaveri, who holds the largest portion among the applicants at 0.81%, and others such as Nina Vijay Shah and Hemant Babubhai Choksi.
Details of Shareholders Seeking Reclassification
The following table outlines the shareholders approved for reclassification along with their respective holdings:
| Sr No. | Name | Number of Equity shares held | % of shareholding |
|---|---|---|---|
| 1. | Madhurika Narendra Shah | 12,000 | 0.01 |
| 2. | Hemant Babubhai Choksi | 24,000 | 0.02 |
| 3. | Mukesh Kantilal Shah | 14,400 | 0.01 |
| 4. | Aruna Navnit Shah | 5,040 | 0.01 |
| 5. | Vikram Kirtilal Shah | 200 | 0.00 |
| 6. | Kiran Piyush Shah | 15,388 | 0.02 |
| 7. | Kinjal Siddharth Jhaveri | 8,16,160 | 0.81 |
| 8. | Nina Vijay Shah | 60,000 | 0.06 |
| 9. | Neela Pradeep Shah | 2,800 | 0.003 |
| TOTAL | 9,49,988 | 0.95 |
Regulatory Compliance and Undertakings
The Board confirmed that these individuals are immediate relatives of promoters and are no longer involved in the day-to-day affairs or management of anuh pharma . They stated that they do not exercise control over the company's affairs or possess special rights through formal or informal arrangements.
The outgoing promoters confirmed they do not hold more than 10% of the total voting rights, are not represented on the Board of Directors, and do not act as key managerial personnel. They also verified that they are not wilful defaulters or fugitive economic offenders, and there is no pending regulatory action against them.
Historical Stock Returns for Anuh Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.87% | +7.07% | +2.90% | +3.56% | -24.33% | -27.43% |
How will the increase in public shareholding to 0.95% impact Anuh Pharma's ability to meet minimum public float requirements?
Does this reclassification signal a broader trend of promoter family members reducing their involvement in the company's management?
Could this shift in shareholding structure lead to changes in the company's corporate governance policies?


































